Takotsubo cardiomyopathy in the USA: clinical outcomes and readmissions in 2013

Back

ESC Premium Access

Takotsubo cardiomyopathy in the USA: clinical outcomes and readmissions in 2013

Session: Cardiomyopathies: understanding the enemy

Topic: Prognosis

Speaker: Doctor A. Tariq (Orange, US)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Doctor Afnan Tariq

University of California, Irvine, Orange (United States of America)

0 follower

8 more presentations in this session

First Australian registry of patients with wild type cardiac amyloidosis (ATTRwt): Queensland experience.

Speaker: Doctor M. Burrage (Brisbane, AU)

Clinical characteristics of ST-elevation and non-ST-elevation types in patients with takotsubo syndrome -a multicenter registry in eight-university hospitals in East Japan

Speaker: Assistant Professor M. Yoshizawa (Morioka, JP)

Myocardial bridging and left ventricular thrombus formation in patients with takotsubo cardiomyopathy

Speaker: Doctor B. Schneider (Luebeck, DE)

Access

Abstract

Risk factors for heart failure after doxorubicin chemotherapy for breast- or colorectal cancer

Speaker: Doctor G. Fogarassy (Balatonfured, HU)

Predictors of heart failure hospitalizations in hypertrophic cardiomyopathy

Speaker: Doctor A. Cecconi (Madrid, ES)

Access the full session

Cardiomyopathies: understanding the enemy

Speakers: Doctor A. Tariq, Doctor M. Burrage, Assistant Professor M. Yoshizawa, Doctor B. Schneider, Doctor G. Fogarassy...

Access

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources